GREY:ATBPF - Post by User
Post by
Ryeman40on Dec 10, 2020 4:46pm
264 Views
Post# 32082025
Long term
Long term This is one of my long term holds. I have a lot of shares and more than likely will buy more if i can. My timeline is around a year.
There has been a few research papers from the Japanese, Korean and Chinese on the incredible benefits of H2S but they all have said more research needs to be done. Enter Antibe.
With the adaptive phase 3 design i believe we should know after 50% of patients have completed treatment if we have an absolute winner. If Antibe doesn't need to increase sample size i think there will be a lot of attention turning Antibes way for a potential blockbuster and there's already been a few in the nsaid market. Pros for adaptive design are reduced potential cost, higher potential success and stakeholder buy-in.
IMHO i believe something like this comes along once in awhile and I've missed out on a few but not this time.